Ariva debate
This article was originally published in The Tan Sheet
Executive Summary
Star Scientific's Internet monitoring program to prevent tobacco distributors from selling its Ariva "cigalett" is inadequate, because at least five Web sites still sell the product, GlaxoSmithKline says in June 14 comments to FDA; the firm has submitted a citizen petition claiming Ariva is an adulterated food. Star had previously asserted it monitors the Internet to prevent Web sales of Ariva (1"The Tan Sheet" May 13, 2002, p. 8). In its own June 13 comments, Star requests a citizen petition filed by the Society for Research on Nicotine & Tobacco be denied "because it states no grounds upon which to predicate FDA jurisdiction" over Ariva. SRNT has "significant relationships with the drug industry, including GSK," Star says, asserting the group is advocating regulation of Ariva because it "appears to be perceived as a threat" to GSK's NiQuitin CQ lozenge, for which GSK is seeking FDA approval...